Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

ALX Oncology Holdings Inc. (ALXO) vs Canton Strategic Holdings, Inc. (CNTN)

ALX Oncology Holdings Inc. and Canton Strategic Holdings, Inc. are both Biotechnology companies. ALX Oncology Holdings Inc. and Canton Strategic Holdings, Inc. are of similar size ($191.2M and $187.4M). ALX Oncology Holdings Inc. has negative trailing earnings, so its P/E is not meaningful; Canton Strategic Holdings, Inc. trades at 13.7×. Across the 10 metrics below, Canton Strategic Holdings, Inc. leads on 9 and ALX Oncology Holdings Inc. on 1.

Valuation

Metric ALXO CNTN Biotechnology median
P/E n/m 13.67 7.88
P/S 72.88 n/m 11.47
P/B 1.30 1.23 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 22.31 n/m 10.73
Earnings yield (86.26%) 7.31% (28.84%)
Free cash flow yield (39.90%) (3.96%) (23.03%)

Profitability

Metric ALXO CNTN Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (80.65%) (43.10%) (57.72%)
Return on assets (63.16%) (34.60%) (49.22%)
Return on invested capital (673.30%) (8.11%) 0.00%

Growth

Metric ALXO CNTN Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 26.36% 88.10% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALXO CNTN Biotechnology median
Debt to equity 0.07 0.00 0.00
Current ratio 9.71 15.70 4.73
Net debt to EBITDA 0.34 0.85 0.96

Dividend

Metric ALXO CNTN Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ALXO CNTN Biotechnology median
Market cap 187.37m 191.23m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack